Synthesis and biological evaluation of EC140: A novel folate-targeted vinca alkaloid conjugate

被引：50

作者：

Leamon, Christopher P. ^{[1
]}

Reddy, Joseph A. ^{[1
]}

Vlahov, Iontcho R. ^{[1
]}

Kleindl, Paul J. ^{[1
]}

Vetzel, Marilynn ^{[1
]}

Westrick, Elaine ^{[1
]}

机构：

[1] Endocyte Inc, W Lafayette, IN 47906 USA

来源：

BIOCONJUGATE CHEMISTRY | 2006年 / 17卷 / 05期

关键词：

D O I：

10.1021/bc060145g

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

A novel folate conjugate of desacetylvinblastine monohydrazide (DAVLBH), herein referred to as EC140, was designed and evaluated for biological activity against folate receptor (FR)-positive cells and tumors. EC140 was produced by coupling a peptidic analogue of the vitamin folic acid to DAVLBH via an acylhydrazone bond. This water-soluble conjugate was found to retain high affinity for FR-positive cells, and it produced specific, dose-responsive activity in vitro. Initial in vivo tests confirmed EC140's activity in both syngeneic and xenograft models. Hence, enduring complete responses were observed in animals bearing established, subcutaneous tumors prior to therapy using regimens that produced minor toxicity. In contrast, treatment with the unconjugated DAVLBH drug produced nominal efficacy when dosed at its MTD. Overall, EC140's performance in vitro and in vivo warrants further preclinical study before this novel targeted chemotherapeutic is considered for clinical investigation.

引用

页码：1226 / 1232

页数：7

共 33 条

[1] Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: Tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy [J].